| T2DM | Prediabetes | Controls | P value |
---|---|---|---|---|
Number of patients : | n = 14 | n = 34 | n = 17 | Â |
Male, n / (%) | 12 / (71) | 15 / (44) | 8 / (47) | n / a |
Age, (years) | 60 ± 6 | 56 ± 8 | 55 ± 7 | ns |
BMI, (kg/m2) | 32 ± 5 | 30± 5 | 28 ± 4.4 | 0.04* |
HbA1c, (mmol HbA1c / mol Hb) | 64 ±16 | 41 ± 3 | 36 ± 2 |  |
LV ejection fraction (%) | 56 ± 6 | 59 ± 5 | 57 ± 5 | ns |
BSA Indexed LV mass (gram/m2) | 54 ± 13 | 47 ± 7 | 50 ± 13 | 0.02* |
Rest MBF, (ml/g/min) | 0.83 ± 0.41 | 0.65 ± 0.24 | 0.78 ± 0.39 | ns |
Peak LV ER, (degrees) : | Â | Â | Â | Â |
Apical LV | 10.05 ± 3.70 | 9.68 ± 3.44 | 7.82 ± 4.08 | ns |
Mid LV | 5.9 ± 3.5 | 5.2 ± 3.7 | 4.3 ± 3.4 | ns |
Basal LV | 2.41 ± 4.20 | 1.52 ± 2.90 | 0.55 ± 3.84 | ns |